MONASHEE INVESTMENT MANAGEMENT
MONASHEE INVESTMENT MANAGEMENT
Social Links:
Industry:
Business Development Financial Services Venture Capital
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Amazon IPv6 Cloudflare Cloudflare Hosting ASP.NET Cloudflare DNS
Similar Organizations
1OAK Financial Group
Asset Management Company / Hedge Fund.
Aurora Investment Management LLC
Aurora Investment Management is a hedge fund portfolios in the alternative investments industry.
Defy.vc
Defy is an early-stage venture fund focused on emerging high-potential opportunities.
Legion Partners
Long-term oriented activist fund
LoftyInc Capital Management
LCM manages social impact investment vehicles such as the LoftyInc Afropreneurs Fund.
Metaplanet Holdings
Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors.
Park West Asset Management
Park West Asset Management is an employee-owned hedge fund sponsor.
TOMS Capital Investment Management
TOMS Capital Investment Management is a Hedge Fund.
XN
XN is a New York-based hedge fund
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | Gossamer Bio | Monashee Investment Management investment in Post-IPO Equity - Gossamer Bio | 120 M USD |
| 2022-04-06 | MoonLake Immunotherapeutics | Monashee Investment Management investment in Post-IPO Equity - MoonLake Immunotherapeutics | 115 M USD |
| 2022-02-24 | Scipher Medicine | Monashee Investment Management investment in Series D - Scipher Medicine | 110 M USD |
| 2022-01-07 | AN2 Therapeutics | Monashee Investment Management investment in Series B - AN2 Therapeutics | 80 M USD |
| 2022-01-05 | Korro Bio | Monashee Investment Management investment in Series B - Korro Bio | 116 M USD |
| 2021-12-27 | Pardes Biosciences | Monashee Investment Management investment in Post-IPO Equity - Pardes Biosciences | 75 M USD |
| 2021-11-29 | HotSpot Therapeutics | Monashee Investment Management investment in Series C - HotSpot Therapeutics | 100 M USD |
| 2021-11-29 | Quell Therapeutics | Monashee Investment Management investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-10-29 | Better Therapeutics | Monashee Investment Management investment in Post-IPO Equity - Better Therapeutics | 70 M USD |
| 2021-10-27 | Skyryse | Monashee Investment Management investment in Series B - Skyryse | 200 M USD |